Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase IIa Clinical Trial
September 29, 2015Aldeyra is now actively studying NS2, an aldehyde-binding small molecule, in three indications - Sjögren-Larsson Syndrome, noninfectious anterior uveitis, and allergic conjunctivitis.
More »
Syndax And Merck Announce First Patients Dosed In Phase 1b/2 Clinical Trial Of Entinostat And Keytruda®
September 28, 2015The goal of the clinical trial is to assess safety and efficacy of Syndax’s entinostat in combination with Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) in patients with non-small cell lung cancer or melanoma.
More »
Neothetics Expands Its Board of Directors With Appointments of Jeffrey Nugent and Hani Zeini
September 28, 2015Mr. Nugent has expertise in building dematology companies, forging industry partnerships, and leading M&A transactions. Mr. Zeini brings experience in pharmaceuticals and medical device industries, as well as the aesthetics and plastic surgery market.
More »